Get informed when a big investor buys or sells
+ FollowNovember 17, 2026 - AI Summary
Loading insider trades…
Loading congress trades…
| Market cap | $19.85 Billion |
|---|---|
| Enterprise Value | $18.32 Billion |
| Annual dividend | $0.14 |
| Dividend yield | 0.64% |
| Earnings per Share | $1 |
| Beta | 0.43 |
| Outstanding Shares | 220,571,854 |
| P/E Ratio | 40.72 |
|---|---|
| PEG | 266.39 |
| Price to Sales | 2.81 |
| Price to Book Ratio | 2.81 |
| Enterprise Value to Revenue | 2.59 |
| Enterprise Value to EBIT | 9.63 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Established in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allergy solutions to markets across Europe,...